In the early stages of SSc, numerous Th17 cells and enhancer levels of IL-17 have been found (79), whereas, in late stages, Th2 cells are dominant T lymphocytes of peripheral blood and skin biopsies that secrete TGF-β, IL-4, and IL-13 (80–82). The gene discussed is TGFB1; the disease is systemic sclerosis.